CORONAVIRUS/Taiwan's CDC to publish Medigen COVID-19 research in U.S. journal
02/02/2024 09:53 PM
A COVID-19 vaccine research from Taiwan-based Medigen Vaccine Biologics Corp., which found its locally-produced vaccine was as effective as the Moderna and Pfizer BioNTech vaccines, will be featured in a United States medical publication.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- COVID-19 epidemic phase to pass mid-August: CDCAlthough Taiwan is still in a COVID-19 epidemic phase, it is expected to pass by mid-August, said the Centers for Disease Control (CDC) at a press conference in Taipei on Tuesday.07/30/2024 08:01 PM
- COVID-19, influenza outbreaks have peaked: CDCCOVID-19 and influenza cases in Taiwan have peaked, with the epidemic phases likely to pass by mid-August, the Centers for Disease Control (CDC) said Tuesday.07/16/2024 08:45 PM
- CDC to buy 5.5 million Moderna JN.1 COVID-19 vaccine shots for October rolloutThe Centers for Disease Control (CDC) on Wednesday announced a plan to purchase 5.5 million doses of the Moderna monovalent JN.1 COVID-19 vaccine, which will be administered, along with the flu vaccine, from Oct. 1.07/10/2024 09:40 PM
Latest
- Business
Labor funds post gains of over NT$1 trillion in 2024
02/03/2025 09:44 PM - Sports
National baseball team opens training for WBC qualifiers
02/03/2025 09:33 PM - Business
Foreign labor may be allowed in waste, recycling industries from March
02/03/2025 09:01 PM - Business
Taiwan plans 1st investment and trade center in Texas
02/03/2025 07:41 PM - Business
Consumer confidence weakens to 8-month low amid Trump fears
02/03/2025 06:48 PM